| September Leigh Wanzenried, APRN | |
|
6901 S 84th St, La Vista, NE 68128 | |
| (866) 389-2727 | |
| Not Available |
| Full Name | September Leigh Wanzenried |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 6901 S 84th St, La Vista, Nebraska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073030607 | NPI | - | NPPES |
| Entity Name | Alegent Health Quick Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215066568 PECOS PAC ID: 3476657370 Enrollment ID: O20070403000169 |
News Archive
As testing for high-risk types of the human papillomavirus (HPV) emerges as the gold standard in cervical cancer prevention, scientists are already researching how to determine even more precisely who is most likely to develop the disease and thus are in need of more immediate intervention.
Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow System, the first rapid and easy-to-use point-of-care diagnostic system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the company has signed an agreement with Portola Pharmaceuticals, Inc. to develop and supply the VerifyNow System and VerifyNowTests for use in clinical trials.
After a bill to extend jobs and economic relief programs failed for the third time in the Senate Thursday, Majority Leader Harry Reid announced he would withdraw the bill, Politico reports. The legislation included financial relief for states, including billions to support Medicaid programs.
A new type of immunotherapy for the skin cancer malignant melanoma shows promising results. Three severely ill patients are now long-term survivors.
AEterna Zentaris Inc., (the "Company") a global biopharmaceutical company focused on endocrine therapy and oncology, announced today that it has completed its previously announced registered direct offering of US$5.5 million of units comprised of common shares and common share purchase warrants to certain institutional investors.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| September Leigh Wanzenried, APRN 5205 Cass St, Omaha, NE 68132-2818 Ph: (402) 301-4348 | September Leigh Wanzenried, APRN 6901 S 84th St, La Vista, NE 68128 Ph: (866) 389-2727 |
News Archive
As testing for high-risk types of the human papillomavirus (HPV) emerges as the gold standard in cervical cancer prevention, scientists are already researching how to determine even more precisely who is most likely to develop the disease and thus are in need of more immediate intervention.
Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow System, the first rapid and easy-to-use point-of-care diagnostic system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the company has signed an agreement with Portola Pharmaceuticals, Inc. to develop and supply the VerifyNow System and VerifyNowTests for use in clinical trials.
After a bill to extend jobs and economic relief programs failed for the third time in the Senate Thursday, Majority Leader Harry Reid announced he would withdraw the bill, Politico reports. The legislation included financial relief for states, including billions to support Medicaid programs.
A new type of immunotherapy for the skin cancer malignant melanoma shows promising results. Three severely ill patients are now long-term survivors.
AEterna Zentaris Inc., (the "Company") a global biopharmaceutical company focused on endocrine therapy and oncology, announced today that it has completed its previously announced registered direct offering of US$5.5 million of units comprised of common shares and common share purchase warrants to certain institutional investors.
› Verified 7 days ago